New World Medical Receives MDR Certification for Glaucoma Devices
News related to:New World Medical · 1 min read
RANCHO CUCAMONGA, Calif., Oct. 6, 2026 /CourierPR/ -- New World Medical has achieved a significant regulatory milestone with the receipt of Medical Device Regulation (MDR) certification for its Ahmed® Glaucoma Valve, Ahmed ClearPath® (ACP), and KDB GLIDE® products in the European Union. This certification marks a successful transition from the previous Medical Device Directive (MDD) framework, ensuring compliance with the updated regulatory requirements in Europe.
The Ahmed® Glaucoma Valve and Ahmed ClearPath® have been commercially available in Europe since their introduction, and the MDR certification underscores the company's commitment to advancing glaucoma care and expanding access to vision-preserving treatment options for both surgeons and patients globally.
The company is also working towards adding additional products to the MDR certification, with a particular focus on the Ahmed ClearPath® ST (ACP ST), which is currently approved in over 20 countries globally and has become a trusted treatment option for surgeons managing refractory glaucoma. Kong highlighted the growing interest in the ACP ST, a next-generation small-tube glaucoma drainage device designed to provide additional surgical flexibility. The MDR certification of ACP represents an important step forward in New World Medical's European growth strategy and establishes a strong regulatory foundation for future expansion of the Ahmed ClearPath portfolio, including ACP ST.
New World Medical's product portfolio includes its flagship devices: the market-leading glaucoma drainage device, the Ahmed® Glaucoma Valve; the Ahmed ClearPath®; the KDB GLIDE®; the STREAMLINE® Surgical System; and the VIA360™ Surgical System. These innovations are designed to provide vision-preserving treatments for patients with glaucoma, reflecting the company's mission to benefit humanity through innovative solutions.
This achievement further strengthens New World Medical's global glaucoma portfolio and supports the company's mission to preserve and enhance vision and benefit humanity through its innovative solutions for patients worldwide.